Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Spectral Medical Inc
Bullboard Posts
User Avatar Image
(25)
•••
Comment by smush74on Nov 24, 2013 9:29pm
236 Views
Post# 21936768

RE:RE:from their 3rd quarter

RE:RE:from their 3rd quarter
sdi only gets US and Canada Toray already has Europe and Japan, not to sure but I think they also China. I can't confirm China, but in the end they only get money from NA the rest belongs to Toray. So we wait until approval. From all the readings to date it appears they are not the inventors or holders of any patents.

from 2010

Spectral Diagnostics Inc., (TSX:SDI), announced that it has signed a long-term, exclusive distribution agreement with Toray Industries, Inc. and Toray Medical Co., Ltd. of Japan (collectively "Toray") to market and sell Toraymyxin™ in Canada.

Toraymyxin™ is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream. This product and Spectral's EAA™ diagnostic, which measures endotoxin and identifies patients for treatment, are already approved for sale by Health Canada.

"We are very pleased to have secured the Canadian distribution rights for this product. In conjunction with the U.S. license …

here is a good link to learn all you want on sepsis

sepsis and endotoxemia therapeutics workbook - Medwell Capital


https://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=9&cad=rja&ved=0CHAQFjAI&url=http%3A%2F%2Fwww.medwellcapital.com%2Fuserfiles%2Ffile%2FSepsis%2520Report%2520Nov%25202010%2520FINAL.pdf&ei=JrOSUv6ZOIHZqAHR4YDoBA&usg=AFQjCNHe5TWuiZjgyFe2rLNKJr5LnNzF8Q&sig2=vkP_poHRTx3g1YLgNIhTxg&bvm=bv.56988011,d.aWM

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities